{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:42:23Z","timestamp":1784698943411,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parvovirus B19 (B19V) causes erythema infectiosum, a.k.a., fifth disease. This disease primarily affects children. It is generally self-limiting and subsides after 1\u20132\u00a0weeks. In pregnancy, the virus can cross the placenta and result in a fetal infection. This may lead to severe fetal anemia, hydrops fetalis, a miscarriage, or intrauterine fetal death. The risk of long-term sequelae also appears to be increased. About one-third of pregnant women are not immune to B19V and, therefore, are at risk to contract a primary infection. The seroconversion rate during pregnancy is generally around 1\u20132%. During a primary infection, maternal\u2013fetal transplacental transmission of B19V occurs in about 30\u201350% of the cases and the risk of fetal infection increases with advancing gestational age. The risk of severe fetal anemia or hydrops is around 3\u20134% overall and is around 6\u20137% if the primary infection occurs before 20\u00a0weeks\u2019 gestation. Fetal monitoring in women with a primary B19V infection includes regular ultrasound examinations looking for evidence of hydrops fetalis and Doppler measurements of the middle cerebral artery peak velocity. Fetal blood sampling is performed if a significant anemia is suspected and, if such is found, an intrauterine blood transfusion is needed. This article provides an overview of the epidemiology, pathogenesis, clinical manifestations, diagnostic methods, and management of B19V infection during pregnancy.<\/jats:p>","DOI":"10.1007\/s00404-024-07644-6","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:02:57Z","timestamp":1722243777000},"page":"2363-2371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prenatal parvovirus B19 infection"],"prefix":"10.1007","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1497-5143","authenticated-orcid":false,"given":"Karl Oliver","family":"Kagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hoopmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegret","family":"Geipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Sonek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"7644_CR1","doi-asserted-by":"publisher","first-page":"2400299","DOI":"10.2807\/1560-7917.es.2024.29.24.2400299","volume":"29","author":"AC Nordholm","year":"2024","unstructured":"Nordholm AC, M\u00f8ller FT, Ravn SF et al (2024) Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, january to march 2024. Eurosurveillance 29:2400299. https:\/\/doi.org\/10.2807\/1560-7917.es.2024.29.24.2400299","journal-title":"Eurosurveillance"},{"key":"7644_CR2","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3390\/v15112261","volume":"15","author":"T Patalon","year":"2023","unstructured":"Patalon T, Saciuk Y, Trotzky D et al (2023) An Outbreak of parvovirus B19 in Israel. Viruses 15:2261. https:\/\/doi.org\/10.3390\/v15112261","journal-title":"Viruses"},{"key":"7644_CR3","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1038\/s41598-024-59582-7","volume":"14","author":"A Russcher","year":"2024","unstructured":"Russcher A, van Boven M, Beninc\u00e0 E et al (2024) Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic. Sci Rep 14:9630. https:\/\/doi.org\/10.1038\/s41598-024-59582-7","journal-title":"Sci Rep"},{"key":"7644_CR4","doi-asserted-by":"publisher","unstructured":"Beck R, Exler S, Enders M (2024) Parvovirus B19-Infektion und Schwangerschaft. Epid Bull 24:3\u20137. https:\/\/doi.org\/10.25646\/12157","DOI":"10.25646\/12157"},{"key":"7644_CR5","unstructured":"S2k-Leitlinie - Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. AWMF Registernummer 093\/001. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/093-001. Accessed 1 July 2024"},{"key":"7644_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/uog.21991","volume":"56","author":"A Khalil","year":"2020","unstructured":"Khalil A, Sotiriadis A, Chaoui R et al (2020) ISUOG Practice guidelines: role of ultrasound in congenital infection. Ultrasound Obstet Gynecol 56:128\u2013151. https:\/\/doi.org\/10.1002\/uog.21991","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7644_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/cmr.00040-16","volume":"30","author":"J Qiu","year":"2017","unstructured":"Qiu J, S\u00f6derlund-Venermo M, Young NS (2017) Human parvoviruses. Clin Microbiol Rev 30:43\u2013113. https:\/\/doi.org\/10.1128\/cmr.00040-16","journal-title":"Clin Microbiol Rev"},{"key":"7644_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/pubmed\/21.4.439","volume":"21","author":"N Crowcroft","year":"1999","unstructured":"Crowcroft N, Roth C, Cohen B, Miller E (1999) Guidance for control of parvovirus B19 infection in healthcare settings and the community. J Public Heal 21:439\u2013446. https:\/\/doi.org\/10.1093\/pubmed\/21.4.439","journal-title":"J Public Heal"},{"key":"7644_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/oemed-2014-102217","volume":"71","author":"A Riipinen","year":"2014","unstructured":"Riipinen A, Sallm\u00e9n M, Hedman L et al (2014) Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland. Occup Environ Med 71:836. https:\/\/doi.org\/10.1136\/oemed-2014-102217","journal-title":"Occup Environ Med"},{"key":"7644_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/s095026880600731x","volume":"135","author":"M Enders","year":"2006","unstructured":"Enders M, Weidner A, Enders G (2006) Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 135:563\u2013569. https:\/\/doi.org\/10.1017\/s095026880600731x","journal-title":"Epidemiol Infect"},{"key":"7644_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/s0140-6736(88)92684-0","volume":"332","author":"T Schwarz","year":"1988","unstructured":"Schwarz T, Roggendorf M, Hottentr\u00e4ger B et al (1988) Human parvovirus B19 Infection in pregnancy. Lancet 332:566\u2013567. https:\/\/doi.org\/10.1016\/s0140-6736(88)92684-0","journal-title":"Lancet"},{"key":"7644_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s15010-010-0035-y","volume":"38","author":"C Reinheimer","year":"2010","unstructured":"Reinheimer C, Allwinn R, Doerr HW, Wittek M (2010) Seroepidemiology of parvovirus B19 in the frankfurt am main area, Germany: evaluation of risk factors. Infection 38:381\u2013385. https:\/\/doi.org\/10.1007\/s15010-010-0035-y","journal-title":"Infection"},{"key":"7644_CR13","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1017\/s0950268807009958","volume":"136","author":"C R\u00f6hrer","year":"2007","unstructured":"R\u00f6hrer C, G\u00e4rtner B, Sauerbrei A et al (2007) Seroprevalence of parvovirus B19 in the German population. Epidemiology Infect 136:1564\u20131575. https:\/\/doi.org\/10.1017\/s0950268807009958","journal-title":"Epidemiology Infect"},{"key":"7644_CR14","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1017\/s0950268807007856","volume":"135","author":"AJ Vyse","year":"2006","unstructured":"Vyse AJ, Andrews NJ, Hesketh LM, Pebody R (2006) The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiology Infect 135:1354\u20131362. https:\/\/doi.org\/10.1017\/s0950268807007856","journal-title":"Epidemiology Infect"},{"key":"7644_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1471-0528.2000.tb13306.x","volume":"107","author":"IP Jensen","year":"2000","unstructured":"Jensen IP, Thorsen P, Jeune B et al (2000) An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. BJOG Int J Obstet Gynaecol 107:637\u2013643. https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb13306.x","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"7644_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10165-010-0338-y","volume":"21","author":"H Oiwa","year":"2011","unstructured":"Oiwa H, Shimada T, Hashimoto M et al (2011) Clinical findings in parvovirus B19 infection in 30 adult patients in Kyoto. Mod Rheumatol 21:24\u201331. https:\/\/doi.org\/10.1007\/s10165-010-0338-y","journal-title":"Mod Rheumatol"},{"key":"7644_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/s0029-7844(97)00701-1","volume":"91","author":"JH Harger","year":"1998","unstructured":"Harger JH, Adler SP, Koch WC, Harger GF (1998) Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 91:413\u2013420. https:\/\/doi.org\/10.1016\/s0029-7844(97)00701-1","journal-title":"Obstet Gynecol"},{"key":"7644_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5858\/2007-131-799-pbiiti","volume":"131","author":"AV Florea","year":"2007","unstructured":"Florea AV, Ionescu DN, Melhem MF (2007) Parvovirus B19 Infection in the Immunocompromised Host. Arch Pathol Lab Med 131:799\u2013804. https:\/\/doi.org\/10.5858\/2007-131-799-pbiiti","journal-title":"Arch Pathol Lab Med"},{"key":"7644_CR19","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/pd.5819","volume":"40","author":"LO Attwood","year":"2020","unstructured":"Attwood LO, Holmes NE, Hui L (2020) Identification and management of congenital parvovirus B19 infection. Prenat Diagn 40:1722\u20131731. https:\/\/doi.org\/10.1002\/pd.5819","journal-title":"Prenat Diagn"},{"key":"7644_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2796.2006.01697.x","volume":"260","author":"K Broliden","year":"2006","unstructured":"Broliden K, Tolfvenstam T, Norbeck O (2006) Clinical aspects of parvovirus B19 infection. J Intern Med 260:285\u2013304. https:\/\/doi.org\/10.1111\/j.1365-2796.2006.01697.x","journal-title":"J Intern Med"},{"key":"7644_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/uog.19092","volume":"52","author":"F Bascietto","year":"2018","unstructured":"Bascietto F, Liberati M, Murgano D et al (2018) Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis. Ultrasound Obst Gyn 52:569\u2013576. https:\/\/doi.org\/10.1002\/uog.19092","journal-title":"Ultrasound Obst Gyn"},{"key":"7644_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/00006454-199806000-00011","volume":"17","author":"WC Koch","year":"1998","unstructured":"Koch WC, Harger JH, Barnstein B, Adler SP (1998) Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 17:489\u2013494. https:\/\/doi.org\/10.1097\/00006454-199806000-00011","journal-title":"Pediatr Infect Dis J"},{"key":"7644_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","volume":"105","author":"E Miller","year":"1998","unstructured":"Miller E, Fairley CK, Cohen BJ, Seng C (1998) Immediate and long term outcome of human parvovirus B19 infection in pregnancy. BJOG Int J Obstet Gynaecol 105:174\u2013178. https:\/\/doi.org\/10.1111\/j.1471-0528.1998.tb10048.x","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"7644_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.placenta.2014.11.003","volume":"36","author":"L Mor\u00e8re","year":"2015","unstructured":"Mor\u00e8re L, Andouard D, Labrousse F et al (2015) Ex vivo model of congenital cytomegalovirus infection and new combination therapies. Placenta 36:41\u201347. https:\/\/doi.org\/10.1016\/j.placenta.2014.11.003","journal-title":"Placenta"},{"key":"7644_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/pd.940","volume":"24","author":"M Enders","year":"2004","unstructured":"Enders M, Weidner A, Zoellner I et al (2004) Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24:513\u2013518. https:\/\/doi.org\/10.1002\/pd.940","journal-title":"Prenat Diagn"},{"key":"7644_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jcv.2010.07.014","volume":"49","author":"M Enders","year":"2010","unstructured":"Enders M, Klingel K, Weidner A et al (2010) Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol 49:163\u2013168. https:\/\/doi.org\/10.1016\/j.jcv.2010.07.014","journal-title":"J Clin Virol"},{"key":"7644_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcv.2019.03.004","volume":"114","author":"Y Xiong","year":"2019","unstructured":"Xiong Y, Tan J, Liu Y et al (2019) The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: a systematic review and meta-analysis. J Clin Virol 114:12\u201320. https:\/\/doi.org\/10.1016\/j.jcv.2019.03.004","journal-title":"J Clin Virol"},{"key":"7644_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejogrb.2015.09.006","volume":"195","author":"DR Hartge","year":"2015","unstructured":"Hartge DR, Weichert J, Gembicki M, Krapp M (2015) Confirmation of etiology in fetal hydrops by sonographic evaluation of fluid allocation patterns. Eur J Obstet Gynecol Reprod Biol 195:128\u2013132. https:\/\/doi.org\/10.1016\/j.ejogrb.2015.09.006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7644_CR29","doi-asserted-by":"publisher","first-page":"3259760","DOI":"10.1155\/2019\/3259760","volume":"2019","author":"O Grubman","year":"2019","unstructured":"Grubman O, Hussain FN, Nelson Z, Brustman L (2019) Maternal parvovirus B19 Infection causing first-trimester increased nuchal translucency and fetal hydrops. Case Rep Obstet Gynecol 2019:3259760. https:\/\/doi.org\/10.1155\/2019\/3259760","journal-title":"Case Rep Obstet Gynecol"},{"key":"7644_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/(sici)1097-0096(199807\/08)26:6<314::aid-jcu6>3.0.co;2-l","volume":"26","author":"JC Smulian","year":"1998","unstructured":"Smulian JC, Egan JFX, Rodis JF (1998) Fetal hydrops in the first trimester associated with maternal parvovirus infection. J Clin Ultrasound 26:314\u2013316. https:\/\/doi.org\/10.1002\/(sici)1097-0096(199807\/08)26:6%3c314::aid-jcu6%3e3.0.co;2-l","journal-title":"J Clin Ultrasound"},{"key":"7644_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/uog.3925","volume":"29","author":"A Kempe","year":"2007","unstructured":"Kempe A, R\u00f6sing B, Berg C et al (2007) First-trimester treatment of fetal anemia secondary to parvovirus B19 infection. Ultrasound Obstet Gynecol 29:226\u2013228. https:\/\/doi.org\/10.1002\/uog.3925","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7644_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/bdra.23588","volume":"109","author":"A Ornoy","year":"2017","unstructured":"Ornoy A, Ergaz Z (2017) Parvovirus B19 infection during pregnancy and risks to the fetus. Birth Defects Res 109:311\u2013323. https:\/\/doi.org\/10.1002\/bdra.23588","journal-title":"Birth Defects Res"},{"key":"7644_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00246-010-9803-9","volume":"32","author":"SG Fishman","year":"2011","unstructured":"Fishman SG, Pelaez LM, Baergen RN, Carroll SJ (2011) Parvovirus-mediated fetal cardiomyopathy with atrioventricular nodal disease. Pediatr Cardiol 32:84\u201386. https:\/\/doi.org\/10.1007\/s00246-010-9803-9","journal-title":"Pediatr Cardiol"},{"key":"7644_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1128\/jcm.01672-08","volume":"47","author":"T Schenk","year":"2009","unstructured":"Schenk T, Enders M, Pollak S et al (2009) High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 47:106\u2013110. https:\/\/doi.org\/10.1128\/jcm.01672-08","journal-title":"J Clin Microbiol"},{"key":"7644_CR35","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00404-023-07006-8","volume":"309","author":"P Siebers","year":"2024","unstructured":"Siebers P, Gembruch U, Merz WM et al (2024) Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment. Arch Gynecol Obstet 309:1341\u20131351. https:\/\/doi.org\/10.1007\/s00404-023-07006-8","journal-title":"Arch Gynecol Obstet"},{"key":"7644_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06712-z","author":"P Kosian","year":"2022","unstructured":"Kosian P, Hellmund A, Geipel A et al (2022) Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection a multicenter retrospective study. Arch Gynecol Obstet. https:\/\/doi.org\/10.1007\/s00404-022-06712-z","journal-title":"Arch Gynecol Obstet"},{"key":"7644_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1471-0528.2007.01555.x","volume":"115","author":"TD Haan","year":"2008","unstructured":"Haan TD, Akker EVD, Porcelijn L et al (2008) Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load. Bjog Int J Obstetrics Gynaecol 115:76\u201381. https:\/\/doi.org\/10.1111\/j.1471-0528.2007.01555.x","journal-title":"Bjog Int J Obstetrics Gynaecol"},{"key":"7644_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/aog.0b013e3181e7597e","volume":"116","author":"M Zajicek","year":"2010","unstructured":"Zajicek M, Gindes L, Hoffmann C et al (2010) Prenatal diagnosis of obstructive hydrocephalus associated with parvovirus B19 Infection. Obstet Gynecol 116:521\u2013522. https:\/\/doi.org\/10.1097\/aog.0b013e3181e7597e","journal-title":"Obstet Gynecol"},{"key":"7644_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1086\/524302","volume":"197","author":"M Enders","year":"2008","unstructured":"Enders M, Weidner A, Rosenthal T et al (2008) Improved Diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis 197:58\u201362. https:\/\/doi.org\/10.1086\/524302","journal-title":"J Infect Dis"},{"key":"7644_CR40","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/jcm.02613-13","volume":"52","author":"PAC Maple","year":"2014","unstructured":"Maple PAC, Hedman L, Dhanilall P et al (2014) Identification of past and recent parvovirus B19 Infection in Immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. J Clin Microbiol 52:947\u2013956. https:\/\/doi.org\/10.1128\/jcm.02613-13","journal-title":"J Clin Microbiol"},{"key":"7644_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1620\/tjem.190.65","volume":"190","author":"N Yaegashi","year":"2005","unstructured":"Yaegashi N (2005) Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med 190:65. https:\/\/doi.org\/10.1620\/tjem.190.65","journal-title":"Tohoku J Exp Med"},{"key":"7644_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/uog.17555","volume":"50","author":"N Abbasi","year":"2017","unstructured":"Abbasi N, Johnson J-A, Ryan G (2017) Fetal anemia. Ultrasound Obstet Gynecol 50:145\u2013153. https:\/\/doi.org\/10.1002\/uog.17555","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7644_CR43","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1067\/mob.2002.128024","volume":"187","author":"E Cosmi","year":"2002","unstructured":"Cosmi E, Mari G, Chiaie LD et al (2002) Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 187:1290\u20131293. https:\/\/doi.org\/10.1067\/mob.2002.128024","journal-title":"Am J Obstet Gynecol"},{"key":"7644_CR44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/uog.20273","volume":"54","author":"RJ Martinez-Portilla","year":"2019","unstructured":"Martinez-Portilla RJ, Lopez-Felix J, Hawkins-Villareal A et al (2019) Performance of fetal middle cerebral artery peak systolic velocity for prediction of anemia in untransfused and transfused fetuses: systematic review and meta-analysis. Ultrasound Obstet Gynecol 54:722\u2013731. https:\/\/doi.org\/10.1002\/uog.20273","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7644_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1046\/j.0960-7692.2001.00540.x","volume":"18","author":"LD Chiaie","year":"2001","unstructured":"Chiaie LD, Buck G, Grab D, Terinde R (2001) Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection. Ultrasound Obstet Gynecol 18:232\u2013236. https:\/\/doi.org\/10.1046\/j.0960-7692.2001.00540.x","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7644_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00404-022-06712-z","volume":"308","author":"P Kosian","year":"2023","unstructured":"Kosian P, Hellmund A, Geipel A et al (2023) Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. a multicenter retrospective study. Arch Gynecol Obstet 308:117\u2013125. https:\/\/doi.org\/10.1007\/s00404-022-06712-z","journal-title":"Arch Gynecol Obstet"},{"key":"7644_CR47","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1111\/trf.16087","volume":"60","author":"M\u00c1 S\u00e1nchez-Dur\u00e1n","year":"2020","unstructured":"S\u00e1nchez-Dur\u00e1n M\u00c1, Higueras MT, Avil\u00e9s-Garc\u00eda M et al (2020) Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years\u2019 experience in a tertiary center. Transfusion 60:2557\u20132564. https:\/\/doi.org\/10.1111\/trf.16087","journal-title":"Transfusion"},{"key":"7644_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejogrb.2019.10.027","volume":"244","author":"NEH Crawford","year":"2020","unstructured":"Crawford NEH, Parasuraman R, Howe DT (2020) Intraperitoneal transfusion for severe, early-onset rhesus disease requiring treatment before 20 weeks of gestation: A consecutive case series. Eur J Obstet Gynecol Reprod Biol 244:5\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.10.027","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7644_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000362812","volume":"36","author":"ITM Lindenburg","year":"2014","unstructured":"Lindenburg ITM, van Kamp IL, Oepkes D (2014) Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 36:263\u2013271. https:\/\/doi.org\/10.1159\/000362812","journal-title":"Fetal Diagn Ther"},{"key":"7644_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/uog.17319","volume":"50","author":"C Zwiers","year":"2017","unstructured":"Zwiers C, Lindenburg ITM, Klumper FJ et al (2017) Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound obstetric gynecol off j of the Int Soc Ultrasound Obstetric Gynecol 50:180\u2013186. https:\/\/doi.org\/10.1002\/uog.17319","journal-title":"Ultrasound obstetric gynecol off j of the Int Soc Ultrasound Obstetric Gynecol"},{"key":"7644_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000530993","volume":"50","author":"A Berezowsky","year":"2023","unstructured":"Berezowsky A, Hochberg A, Regev N et al (2023) Intrauterine blood transfusion for parvo B19-induced fetal anemia: neuroimaging findings and long-term neurological outcomes. Fetal Diagn Ther 50:206\u2013214. https:\/\/doi.org\/10.1159\/000530993","journal-title":"Fetal Diagn Ther"},{"key":"7644_CR52","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/pd.4152","volume":"33","author":"ITM Lindenburg","year":"2013","unstructured":"Lindenburg ITM, van Klink JM, Smits-Wintjens VEHJ et al (2013) Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review. Prenat Diagn 33:815\u2013822. https:\/\/doi.org\/10.1002\/pd.4152","journal-title":"Prenat Diagn"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07644-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07644-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07644-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T09:04:23Z","timestamp":1729069463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07644-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["7644"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07644-6","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"7 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Karl Oliver Kagan, Annegret Geipel and Jiri Sonek are editors of the Archives of Gynecology and Obstetrics. Karl Oliver Kagan is the Editor in Chief.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors affirm that the human research participants provided informed consent for publication of the images. All authors have agreed to publishing of this manuscript in the Archives of Gynecology and Obstetrics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}